DUBLIN--(BUSINESS WIRE)--The "Transdermal
Drug Delivery - Technologies, Markets, and Companies" report
from Jain PharmaBiotech has been added to ResearchAndMarkets.com's
This report deals with transdermal drug delivery - an approach used to
deliver drugs through the skin for therapeutic use as an alternative to
oral, intravascular, subcutaneous and transmucosal routes.
Various transdermal drug delivery technologies are described including
the use of suitable formulations, carriers and penetration enhancers.
The most commonly used transdermal system is the skin patch using
various types of technologies. Nanoparticles as well as the use of
physical agents to facilitate transcutaneous drug delivery is described.
Microneedle and needleless technologies are also described.
Transdermal technologies may be applied for several categories of
pharmaceuticals used for the treatment of disorders of the skin or for
systemic effect to treat diseases of other organs. Several transdermal
products and applications include hormone replacement therapy,
contraception, management of pain, angina pectoris, smoking cessation
and neurological disorders such as Parkinson's disease.
The market for transdermal drug delivery is analyzed according to technologies and therapeutic areas from 2017 to 2027. This market is analyzed according to geographical regions as well.
Benefits of this report
- Up-to-date one-stop information on transdermal drug delivery
- Description of 112 companies involved and 112 collaborations in this area
- Market analysis 2017-2027
- Market values in major regions
- Strategies for developing markets for transdermal drug delivery
- A selected bibliography of 220 publications
- Text is supplemented by 22 tables and 16 figures
Key Topics Covered:
1. Basics of Transdermal Drug Delivery
2. Transdermal Drug Delivery Technologies
3. Transdermal Therapeutics
4. Markets for Transdermal Drug Delivery
5. Companies involved in transdermal drug delivery
For more information about this report visit https://www.researchandmarkets.com/research/k9g658/transdermal_drug?w=4